BOULDER, Colo., Feb. 1 /PRNewswire-FirstCall/ -- Array BioPharma Inc. today announced that its Chief Executive Officer, Robert E. Conway, will speak at the BIO CEO & Investor Conference on February 15 in New York City. The public is welcome to participate in the conference through an audio webcast on the Array BioPharma website.
Event: BIO CEO & Investor Conference Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma Date: Wednesday, February 15, 2006 Time: 11:30 am Eastern Time Location: Waldorf Astoria, New York City Audio Webcast: www.arraybiopharma.com About Array BioPharma:
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
Array BioPharma Inc.
CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193,thaugeto@arraybiopharma.com
Web site: http://www.arraybiopharma.com/
Company News On-Call: http://www.prnewswire.com/comp/638569.html /
